IMPORTANT: This is a new action! Even if you’ve already contacted your congressional representatives about establishing the patient registry, please also take this action targeted at Congresswoman Nita Lowey (D-NY 17th District) and Congresswoman Rosa DeLauro (D-CT 3rd District).
Adding immunotherapy to chemotherapy plus bevacizumab shows promising benefit in survival for non-epitheliod mesothelioma patients, but not across the board
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free